Patents by Inventor Kris GELLYNCK

Kris GELLYNCK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11339373
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: May 24, 2022
    Assignee: Promethera Therapeutics SA
    Inventors: Etienne Sokal, Sarah Snykers, Tuba Baran, Kris Gellynck, Luca Falciola
  • Publication number: 20200095554
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Application
    Filed: November 26, 2019
    Publication date: March 26, 2020
    Inventors: Etienne SOKAL, Sarah SNYKERS, Tuba BARAN, Kris GELLYNCK, Luca FALCIOLA
  • Patent number: 10538741
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: January 21, 2020
    Assignee: Promethera Biosciences S.A./N.V.
    Inventors: Etienne Sokal, Sarah Snykers, Tuba Baran, Kris Gellynck, Luca Falciola
  • Publication number: 20190134098
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Application
    Filed: January 7, 2019
    Publication date: May 9, 2019
    Inventors: Etienne SOKAL, Sarah SNYKERS, Tuba BARAN, Kris GELLYNCK
  • Patent number: 10172889
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: January 8, 2019
    Assignee: Promethera Biosciences S.A./N.V.
    Inventors: Etienne Sokal, Sarah Snykers, Tuba Baran, Kris Gellynck
  • Publication number: 20170240863
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Application
    Filed: August 28, 2015
    Publication date: August 24, 2017
    Inventors: Etienne SOKAL, Sarah SNYKERS, Tuba BARAN, Kris GELLYNCK, Luca FALCIOLA
  • Publication number: 20160206664
    Abstract: Novel adult liver progenitor cells (called H2Stem Cells) have been have been characterized on the basis of a series of biological activities and markers. Methods for producing H2Stem Cells allow providing such cells in the form of adherent cells and three-dimensional cell clusters in suspension that can be differentiated into cells having strong liver-specific activities and/or that can be used for treating liver diseases or for evaluating the efficacy, the metabolism, and/or toxicity of a compound.
    Type: Application
    Filed: August 28, 2014
    Publication date: July 21, 2016
    Applicant: Promethera Biosciences S. A./N.V.
    Inventors: Etienne SOKAL, Sarah SNYKERS, Tuba BARAN, Kris GELLYNCK